Results: 1-22 |

Table of contents of journal: *Annals of oncology

Results: 22

Citation: FRANCE - HUMAN GENOME NOT FOR SALE, Annals of oncology, 3(3), 1992, pp. 176-177

Citation: ITALIAN ONCOLOGISTS - ADMIRED BY PATIENTS BUT NOT ALWAYS BY COLLEAGUES, Annals of oncology, 3(3), 1992, pp. 176-176

Authors: DICKMAN S
Citation: S. Dickman, SOVIET CANCER-TREATMENT AND RESEARCH - AN EYEWITNESS REPORT, Annals of oncology, 3(3), 1992, pp. 177-178

Authors: PICCART MJ DEVALERIOLA D TOMIAK E
Citation: Mj. Piccart et al., ANTHRACYCLINES ACTIVE VIA THE ORAL ROUTE - LUXURY OR NECESSITY, Annals of oncology, 3(3), 1992, pp. 181-182

Authors: CABANILLAS F
Citation: F. Cabanillas, TO CHOP OR NOT TO CHOP - IS THAT THE QUESTION, Annals of oncology, 3(3), 1992, pp. 183-185

Authors: DEBELLEFEUILLE C MORRISON CA TANNOCK IF
Citation: C. Debellefeuille et al., THE FATE OF ABSTRACTS SUBMITTED TO A CANCER MEETING - FACTORS WHICH INFLUENCE PRESENTATION AND SUBSEQUENT PUBLICATION, Annals of oncology, 3(3), 1992, pp. 187-191

Authors: JOSS RA
Citation: Ra. Joss, 6TH WORLD CONFERENCE ON LUNG-CANCER - MELBOURNE, NOVEMBER 10TH-14TH, 1991, Annals of oncology, 3(3), 1992, pp. 193-195

Authors: WILS J WAGENER DJT
Citation: J. Wils et Djt. Wagener, COMBINED MODALITY ADJUVANT TREATMENT OF HIGH-RISK RECTAL-CANCER - A TREATMENT OF CHOICE OR A CHOICE OF TREATMENT, Annals of oncology, 3(3), 1992, pp. 197-199

Authors: STEWART DJ EISENHAUER EA SKILLINGS J PRITCHARD KI BUCKMAN R VANDENBERG T VERMA S AITKEN S NORRIS B
Citation: Dj. Stewart et al., PHASE-II STUDY OF ORAL MENOGARIL AS 1ST LINE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY, Annals of oncology, 3(3), 1992, pp. 201-204

Authors: PAVLOVSKY S SANTARELLI MT ERAZO A MAQUEO JCD SOMOZA N GONALONS ML CERVANTES G VELA ELG CORRADO C MAGNASCO H MILONE G
Citation: S. Pavlovsky et al., RESULTS OF A RANDOMIZED STUDY OF PREVIOUSLY-UNTREATED INTERMEDIATE AND HIGH-GRADE LYMPHOMA USING CHOP VERSUS CNOP, Annals of oncology, 3(3), 1992, pp. 205-209

Authors: PIZZOCARO G SALVIONI R PIVA L FAUSTINI M NICOLAI N GIANNI L
Citation: G. Pizzocaro et al., MODIFIED CISPLATIN, ETOPOSIDE (OR VINBLASTINE) AND IFOSFAMIDE SALVAGETHERAPY FOR MALE GERM-CELL TUMORS - LONG-TERM RESULTS, Annals of oncology, 3(3), 1992, pp. 211-216

Authors: KJORSTAD K HARRIS A BERTELSEN K SLEVIN M SCHULTZ H HELLMAN K JANSSENS N MARTIN A CANETTA R
Citation: K. Kjorstad et al., A MULTICENTER PHASE-II STUDY OF CARBOPLATIN IN ADVANCED OVARIAN-CARCINOMA - FINAL REPORT, Annals of oncology, 3(3), 1992, pp. 217-222

Authors: SCHORNAGEL JH VERWEIJ J DEMULDER PHM COGNETTI F VERMORKEN JB CAPPELAERE P ARMAND JP WILDIERS J CLAVEL M KIRKPATRICK A LEFEBVRE JL
Citation: Jh. Schornagel et al., A PHASE-II TRIAL OF 10-ETHYL-10-DEAZA-AMINOPTERIN, A NOVEL ANTIFOLATE, IN PATIENTS WITH ADVANCED AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Annals of oncology, 3(3), 1992, pp. 223-226

Authors: SPINOLO JA CABANILLAS F DIXON DO KHORANA SM MCLAUGHLIN P VELASQUEZ WS HAGEMEISTER FB REDMAN JR SWAN F
Citation: Ja. Spinolo et al., THERAPY OF RELAPSED OR REFRACTORY LOW-GRADE FOLLICULAR LYMPHOMAS - FACTORS ASSOCIATED WITH COMPLETE REMISSION, SURVIVAL AND TIME TO TREATMENT FAILURE, Annals of oncology, 3(3), 1992, pp. 227-232

Authors: TAGLIABUE G FILIPPESCHI S HENDRICKS H DINCALCI M
Citation: G. Tagliabue et al., ANTITUMOR-ACTIVITY OF 1,4-BIS (2'-CHLOROETHYL)-1,4-DIAZABICYCLO-[2.2.1] HEPTANE DIMALEATE (DABIS MALEATE) IN M5076 AND ITS SUBLINE RESISTANT TO CYCLOPHOSPHAMIDE M5 CTX/, Annals of oncology, 3(3), 1992, pp. 233-236

Authors: MAGRI MD FOLADORE S VERONESI A SERRA C NICOTRA M TOMMASI M GRANDI G MONFARDINI S BIANCHI C
Citation: Md. Magri et al., TREATMENT OF MALIGNANT MESOTHELIOMA WITH EPIRUBICIN AND IFOSFAMIDE - A PHASE-II COOPERATIVE STUDY, Annals of oncology, 3(3), 1992, pp. 237-238

Authors: HENDRICK AM SIMMONS D CANTWELL BMJ
Citation: Am. Hendrick et al., ALLERGIC REACTIONS TO CARBOPLATIN, Annals of oncology, 3(3), 1992, pp. 239-240

Authors: VERWEIJ J PLANTING AST DEBOER M VANDERBURG MEL STOTER G
Citation: J. Verweij et al., FREQUENT ADMINISTRATION OF DABIS MALEATE, A PHASE-I STUDY, Annals of oncology, 3(3), 1992, pp. 241-242

Authors: BAARS JW WAGSTAFF J HACK CE WOLBINK GJ EERENBERGBELMER AJM PINEDO HM
Citation: Jw. Baars et al., ANGIONEUROTIC-EDEMA AND URTICARIA DURING THERAPY WITH INTERLEUKIN-2 (IL-2), Annals of oncology, 3(3), 1992, pp. 243-244

Authors: DICOSTANZO F
Citation: F. Dicostanzo, BEST TREATMENT FOR COLORECTAL-CANCER AND CONFIRMATORY TRIALS, Annals of oncology, 3(3), 1992, pp. 245-245

Authors: HAMILTON JM
Citation: Jm. Hamilton, BEST TREATMENT FOR COLORECTAL-CANCER AND CONFIRMATORY TRIALS - REPLY, Annals of oncology, 3(3), 1992, pp. 245-246

Authors: CANTWELL BMJ HENNESSY C SAWAN A DAWES PJDK MILLWARD M LENNARD TWJ
Citation: Bmj. Cantwell et al., PRIMARY TUMOR MUTANT P53 GENE PROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AND DOXORUBICIN PLUS IFOSFAMIDE FOR RECURRENT BREAST-CANCER, Annals of oncology, 3(3), 1992, pp. 246-247
Risultati: 1-22 |